BIS Research - Emerging Technology Market Intelligence

A Bold Step by Chinese Scientist; Boon or Bane for CRISPR Technology?

Dec 5, 2018 5:01:57 AM / by BIS Research posted in crispr technology, CRISPR Technology Market, CRISPR Technology Market share, what is crispr technology, applications of crispr technology, crispr cas technology, crispr cas9 technology, crispr gene technology, crispr news, crispr technology companies, CRISPR Technology Market forecast, CRISPR Technology Market report, CRISPR Technology Market trends, CRISPR Technology Market value, CRISPR Technology Marketresearch, Global CRISPR Technology Market, Healthcare & Medical

0 Comments

Written by BIS Research Analysts Chanda ManuKoushik and Sanya Behl

Chinese have always been at the forefront to go ahead and unleash the complete potential of the genome editing technologies. Recently, in November 2018, a Chinese scientist, He Jiankui’s claim has perplexed the entire scientific community. With his claim to be the first one to edit viable human embryos genetically, He Jiankui has conveyed his reluctance toward following ethical code and conduct. He aims to eliminate the risk of HIV infection in the babies, using gene editing technologies. Despite the aim being noble, the methodology involves several potential risks.

Read More

CRISPR Technology to Target the Root of Genetic Diseases

Apr 20, 2018 5:03:19 AM / by BIS Research posted in crispr technology, CRISPR Technology Market, CRISPR Technology Market share, what is crispr technology, applications of crispr technology, crispr cas technology, crispr cas9 technology, crispr gene technology, crispr technology companies, CRISPR Technology Market forecast, CRISPR Technology Market report, CRISPR Technology Market trends, CRISPR Technology Market value, CRISPR Technology Marketresearch, Global CRISPR Technology Market, Market Research Report

0 Comments

With the increase in the environmental factors such as chemical, radioactive, and biological factors have elevated the rate of mutation. This, in turn, escalated the need for the development of better gene therapeutic procedures such as CRISPR technology, which is simple and takes less turnaround time as compared to existing technologies. CRISPR technology is gaining immense popularity in gene therapeutic procedures owing to the increase in genetic diseases. Genetic diseases accounted for approximately 25% of the global economic burden for diseases. Therefore, CRISPR technology is being used for better treatment and quality of life of patients. According to the latest market intelligence report by BIS Healthcare titled, ‘Global CRISPR Technology Market-Analysis and Forecast (2018-2027), the market is anticipated to reach $10.55 billion by the year 2027. Further, the prominent companies in the market are planning to initiate clinical trials in the year 2018, for the treatment of various genetic diseases.

Read More

    Subscribe to Email Updates

    Lists by Topic

    see all

    Have Questions? Schedule a Call